COMPLICATIONS OF GASTROESOPHAGEAL REFLUX DISEASE IN ELDERLY PATIENTS
- Authors: Onuchlna E.1, Brlkova S.2, Belikova Y.2, Gontarenko S.2
-
Affiliations:
- Irkutsk State Medical Academy of Postgraduate Education
- War Veterans Hospital
- Issue: Vol 26, No 6 (2015)
- Pages: 54-57
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116319
- ID: 116319
Cite item
Open Access
Access granted
Abstract
The incidence of complicated gastroesophageal reflux disease is more than 2.5-fold higher in elderly people. The age factor is of the greatest importance for mucosal ulceration in the distal esophagus. The proton pump inhibitor (PPI)-alginate (Gaviscon®) combination is a more pathogenetically sound treatment than PPI monotherapy.
Full Text
About the authors
E. Onuchlna
Irkutsk State Medical Academy of Postgraduate Education
Email: elonu@mail.ru
S. Brlkova
War Veterans HospitalIrkutsk
Yu. Belikova
War Veterans HospitalIrkutsk
S. Gontarenko
War Veterans HospitalIrkutsk
References
- Онучина Е.В., Брикова С.И., Цуканов В.В. Использование препарата Гевискон для купирования симптоматики пищеводных, внепищеводных синдромов и функциональной диспепсии у больных ГЭРБ пожилого и старческого возраста // Эксперим. и клин. гастроэнтерол. - 2010; 10: 80-6.
- Онучина Е.В. Клинические проявления, факторы риска и эффективность лечения гастроэзофагеальной рефлюксной болезни у лиц пожилого возраста. Автореф. дис..д-ра мед. наук. Красноярск, 2011; с. 45.
- Ang, D., Sifrim D., Tack J. Mechanisms of heartburn // Nat. Clin. Pract. Gastroenterol. Hepatol. - 2008; 5: 383-92.
- Corley D., Kubo A., Levin T. et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006 // Gut. - 2009; 58: 182-8.
- Farré R., Fornari F., Blondeau K. et al. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus // Gut. - 2010; 59: 164-9.
- Kwiatek M., Roman S., Fareeduddin A. et al. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients // Aliment. Pharmacol. Ther. - 2011; 34: 59-66.
- Lien H., Chang C., Yeh H. et al. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods // J. Clin. Gastroenterol. - 2009; 43: 926-32.
- Lundell L., Dent J., Bennet J. Endoscopic assessment of oesophagitis clinical and functional correlates and futher validation of Los Angeles classification // Gut. - 1999; 45: 72-180.
- Murray L., Watson P., Johnston B. et al. Risk of adenocarcinoma in Barrett's oesophagus: population based study // BMJ. - 2003; 327: 534-5.
- Salvioli G., Tambara E., Gaetti E. et al. Chemico-physical property and bile acid binding capacity of several antacids // Minerva Dietol/Gastroenterol. - 1989; 35: 79-83.
- Savarino E., de Bortoli N., Zentilin P. et al. Alginate controls hear burn in patients with erosive and nonerosive reflux disease // World J. Gastroenterol. -2012; 18: 4371-8.
- Spechler S., Sharma P., Souza R. et al. American Gastroenterological Association technical review on the management of Barrett's esophagus // Gastroenterology. - 2011; 140: 18-52.
- Strugala V., Avis J., Jolliffe I.G. et al. The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease? // J. Pharm. Pharmacol. - 2009; 61: 1021-8.
- Vakil N., van Zanten S., Kahrilas P. et al. The Monreal Definition and Classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterology. - 2006; 101: 1900-20.
- Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy // Am. J. Gastroenterol. - 2006; 101: 1956-63.
- Hampson F. et al. Alginate rafts and their characterization // Int. J. Pharm. -2005; 294 (1-2): 137-47.
Supplementary files
